HealthAlzheimer's Drug Donanemab Shows Promise in Slowing Progression Eli Lilly's drug has the potential to halt the progression of Alzheimer's disease in its early stages.by Quincy Jon
HealthDiet Coke Dangers Revealed: Here's Why You Should Avoid Beverages with Artificial Sweetenersby Quincy Jon
HealthUniversity of Rochester's AI-Based Method Breaks New Ground for Alzheimer's Researchby Quincy Jon